<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Oculus Innovative Sciences Inc. | Company News & Executive Profiles - OCLS | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Oculus Innovative Sciences Inc.]]></description>
	<s:counts start="0" returned="9" found="9" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Oculus Wins China Approval for Animal Wound Product]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F173723-oculus-wins-china-approval-for-animal-wound-product%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  Oculus Innovative Sciences (NSDQ: OCLS) of California reported that its partners have received China regulatory approval to market its wound healing solution as an animal product. Based on the company&#8217;s Microcyn technology, Vetericyn products speed the healing of wounds while fighting infection. Bayer (BAYRY.PK) Animal Health...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 17 Nov 2009 01:01:02 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/chinabio+today.html"><![CDATA[ChinaBio Today]]></category>
		<category domain="http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html"><![CDATA[Oculus Innovative Sciences Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
		<category domain="tickers">OCLS</category>
	</item>
	<item>
		<title><![CDATA[Oculus's New Product Can Tap into Several Billion Dollar Markets]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F157609-oculus-s-new-product-can-tap-into-several-billion-dollar-markets%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[This is not your typical biotech story. This is not a company waiting for a phase three study or an FDA decision in order to become profitable. This is now a commercial story with a company that is being very aggressive in their pursuit of additional revenues and a solid...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 21 Aug 2009 11:22:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/m.+e.+garza.html"><![CDATA[M. E. Garza]]></category>
		<category domain="http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html"><![CDATA[Oculus Innovative Sciences Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
		<category domain="tickers">OCLS</category>
	</item>
	<item>
		<title><![CDATA[Positive News Ahead for Oculus Innovative Sciences]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F156631-positive-news-ahead-for-oculus-innovative-sciences%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[I wanted to give our readers at BiomedReports and beyond a heads up about some news that may move Oculus' OCLS stock upward in the next day or so. This is a company that recently announced financial and operating results for the first quarter of fiscal year 2010, ended June...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 17 Aug 2009 02:40:27 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/m.+e.+garza.html"><![CDATA[M. E. Garza]]></category>
		<category domain="http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html"><![CDATA[Oculus Innovative Sciences Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
		<category domain="tickers">OCLS</category>
	</item>
	<item>
		<title><![CDATA[China Biopharma Week in Review: Broad Views, Individual Companies]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F95382-china-biopharma-week-in-review-broad-views-individual-companies%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  In ChinaBio Today over the past five days, we featured three broad overviews of the China biomedical world, each sourced from an outside publication. The news these articles imparted may seem familiar to our regular readers, who are very aware of the transformation taking place in...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 14 Sep 2008 08:27:22 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/china.html"><![CDATA[China]]></category>
		<category domain="http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html"><![CDATA[Oculus Innovative Sciences Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sinovac+biotech+ltd..html"><![CDATA[Sinovac Biotech Ltd.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVA</category>
		<category domain="tickers">OCLS,SVA</category>
	</item>
	<item>
		<title><![CDATA[Oculus Launches Wound Treatment Product in China]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F95380-oculus-launches-wound-treatment-product-in-china%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[ChinaBio Today submits:  Oculus Innovative Sciences OCLS is launching its Dermacyn wound treatment product in China by sending samples of the product to hospitals in ten China provinces. Sinopharm, the company in charge of China distribution of the product, also featured Dermacyn at a recent trade show, the New...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 14 Sep 2008 08:17:32 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html"><![CDATA[Oculus Innovative Sciences Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
		<category domain="tickers">OCLS</category>
	</item>
	<item>
		<title><![CDATA[Oculus Innovative Sciences, Inc. F4Q08 (Qtr End 03/31/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14046_23-226152.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions Your first question comes from the line of Dan Stall &#8211; Private Investor Dan Stall &#8211; Private Investor  I just wondered if you could address the investors who were at a cost basis of $18.00 a share looking at the stock trading...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 11 Jun 2008 18:10:27 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html"><![CDATA[Oculus Innovative Sciences Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
		<category domain="tickers">OCLS</category>
	</item>
	<item>
		<title><![CDATA[Oculus Innovative Sciences to Participate in Third Congress of the World Union of Wound Healing Societies in Toronto]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_15/ai_n25428982]]></link>
		<description><![CDATA[Microcyn[R] Technology Demonstrates In Vivo Anti-Inflammatory/Wound Healing Properties  PETALUMA, Calif. -- Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops and markets innovative, stable oxychlorine compounds based on the Microcyn[R] Technology platform that are intended to treat a wide range of infections, including those in chronic and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 15 May 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/infection.html"><![CDATA[infection]]></category>
		<category domain="http://resources.bnet.com/topic/mexico.html"><![CDATA[Mexico]]></category>
		<category domain="http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html"><![CDATA[Oculus Innovative Sciences Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+congress.html"><![CDATA[U.S. Congress]]></category>
		<category domain="http://resources.bnet.com/topic/wound.html"><![CDATA[wound]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
		<category domain="tickers">OCLS</category>
	</item>
	<item>
		<title><![CDATA[Oculus Innovative Sciences, Inc., Announces $13.9 Million Securities Offering]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_28/ai_n24961601]]></link>
		<description><![CDATA[PETALUMA, Calif. -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), today announced an offering to sell securities to selected institutional investors for aggregate gross proceeds of $13,926,533. The offering is made pursuant to the Form S-3 shelf registration statement that was filed by Oculus with the Securities and Exchange Commission (the "SEC")...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 28 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html"><![CDATA[Oculus Innovative Sciences Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://resources.bnet.com/topic/wound.html"><![CDATA[wound]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
		<category domain="tickers">OCLS</category>
	</item>
	<item>
		<title><![CDATA[Progressive Following on Oculus Innovative Sciences, Inc.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200803/ai_n25269105]]></link>
		<description><![CDATA[M2 PRESSWIRE-28 March 2008-Street Tips: Progressive Following on  Oculus Innovative Sciences, Inc.C1994-2008 M2 COMMUNICATIONS LTD    RDATE:28032008    Streetinvesting.com has now resumed our progressive review of  Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) as it fell down $0.84 on  over 260,000 more than five times...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 28 Mar 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/oculus+innovative+sciences+inc..html"><![CDATA[Oculus Innovative Sciences Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[SECURITY]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
		<category domain="tickers">OCLS</category>
	</item>
</channel>
</rss>
